UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1569-1579

2020

Volltextzugriff (PDF)

Current status and application of proton therapy for esophageal cancer

Radiotherapy and oncology, 2021-11, Vol.164, p.27-36

2021

Volltextzugriff (PDF)

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial

The Lancet (British edition), 2023-09, Vol.402 (10405), p.871-881

2023

Volltextzugriff (PDF)

Awakening the immune system with radiation: Optimal dose and fractionation

Cancer letters, 2015-11, Vol.368 (2), p.185-190

2015

Volltextzugriff (PDF)

Transcription of functionally related constitutive genes is not coordinated

Nature structural & molecular biology, 2011-01, Vol.18 (1), p.27-34

2011

Volltextzugriff (PDF)

Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLC

Radiotherapy and oncology, 2021-10, Vol.163, p.114-118

2021

Volltextzugriff (PDF)

Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial

The lancet oncology, 2022-10, Vol.23 (10), p.1321-1331

2022

Volltextzugriff (PDF)

Macrophage-dependent tumor cell transendothelial migration is mediated by Notch1/Mena INV -initiated invadopodium formation

Scientific reports, 2016-11, Vol.6, p.37874

2016

Volltextzugriff (PDF)

Macrophage-dependent tumor cell transendothelial migration is mediated by Notch1/MenaINV-initiated invadopodium formation

Scientific reports, 2016-11, Vol.6 (1), p.37874-37874, Article 37874

2016

Volltextzugriff (PDF)

Assessment of Prognostic Value of High-Sensitivity Cardiac Troponin T for Early Prediction of Chemoradiation Therapy-Induced Cardiotoxicity in Patients with Non-Small Cell Lung Cancer: A Secondary Analysis of a Prospective Randomized Trial

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (4), p.907-916

2021

Volltextzugriff (PDF)

Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced disease

The Journal of thoracic and cardiovascular surgery, 2024-06, Vol.167 (6), p.1929-1935.e2

2024

Volltextzugriff (PDF)

SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection

International journal of radiation oncology, biology, physics, 2024-03, Vol.118 (4), p.971-978

2024

Volltextzugriff (PDF)

Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?

Seminars in radiation oncology, 2018-04, Vol.28 (2), p.114-124

2018

Volltextzugriff (PDF)

Management of Bronchial Adenoma/Ciliated Muconodular Papillary Tumor with Definitive Stereotactic Body Radiation Therapy (SBRT): A Case Report

Clinical lung cancer, 2022-07, Vol.23 (5), p.e335-e338

2022

Volltextzugriff (PDF)

Metabolic cycling in single yeast cells from unsynchronized steady-state populations limited on glucose or phosphate

Proceedings of the National Academy of Sciences - PNAS, 2010-04, Vol.107 (15), p.6946-6951

2010

Volltextzugriff (PDF)

Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non–small-cell Lung Cancer

Clinical lung cancer, 2021-09, Vol.22 (5), p.e745-e755

2021

Volltextzugriff (PDF)

Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear Analysis

International journal of radiation oncology, biology, physics, 2020-08, Vol.107 (5), p.897-908

2020

Volltextzugriff (PDF)

A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model

Journal of nanobiotechnology, 2021-12, Vol.19 (1), p.416-416, Article 416

2021

Volltextzugriff (PDF)

I-SABR phase II randomized study of nivolumab immunotherapy and stereotactic ablative radiotherapy in early stage NSCLC: Interim analysis adverse effects

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9035-9035

2020

Volltextzugriff (PDF)

An improved method for analyzing and reporting patterns of in-field recurrence after stereotactic ablative radiotherapy in early-stage non-small cell lung cancer

Radiotherapy and oncology, 2020-04, Vol.145, p.209-214

2020

Volltextzugriff (PDF)

Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer

Journal of nanobiotechnology, 2022-09, Vol.20 (1), p.1-417, Article 417

2022

Volltextzugriff (PDF)

Preclinical rationale for combining radiation therapy and immunotherapy beyond checkpoint inhibitors (i.e., CART)

Translational lung cancer research, 2017-04, Vol.6 (2), p.159-168

2017

Volltextzugriff (PDF)

Clinical decision tool for optimal delivery of liver stereotactic body radiation therapy: Photons versus protons

Practical Radiation Oncology, 2015-07, Vol.5 (4), p.209-218

2015

Volltextzugriff (PDF)

NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model

Frontiers in immunology, 2022-11, Vol.13, p.1022011-1022011

2022

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(79)

Publikationsform

Sprache

Englisch
(89)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(48)
Humans
(34)
Oncology
(34)
Radiology, Nuclear Medicine & Medical Imaging
(18)
Lung Cancer
(14)
Immunotherapy
(13)
Female
(12)
Aged
(11)
Retrospective Studies
(10)
Tumors
(10)
Cancer Therapies
(9)
Lung Neoplasms - Pathology
(9)
Lung Neoplasms - Radiotherapy
(9)
Male
(9)
Radiation
(7)
Radiation Therapy
(7)
Surgery
(7)
Animals
(6)
Carcinoma, Non-Small-Cell Lung - Radiotherapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer

Current status and application of proton therapy for esophageal cancer

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial

Awakening the immune system with radiation: Optimal dose and fractionation

Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer

Transcription of functionally related constitutive genes is not coordinated

Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLC

Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial

Macrophage-dependent tumor cell transendothelial migration is mediated by Notch1/Mena INV -initiated invadopodium formation

Macrophage-dependent tumor cell transendothelial migration is mediated by Notch1/MenaINV-initiated invadopodium formation

Assessment of Prognostic Value of High-Sensitivity Cardiac Troponin T for Early Prediction of Chemoradiation Therapy-Induced Cardiotoxicity in Patients with Non-Small Cell Lung Cancer: A Secondary Analysis of a Prospective Randomized Trial

Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced disease

SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection

Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?

Management of Bronchial Adenoma/Ciliated Muconodular Papillary Tumor with Definitive Stereotactic Body Radiation Therapy (SBRT): A Case Report

Metabolic cycling in single yeast cells from unsynchronized steady-state populations limited on glucose or phosphate

Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non–small-cell Lung Cancer

Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear Analysis

A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model

I-SABR phase II randomized study of nivolumab immunotherapy and stereotactic ablative radiotherapy in early stage NSCLC: Interim analysis adverse effects

An improved method for analyzing and reporting patterns of in-field recurrence after stereotactic ablative radiotherapy in early-stage non-small cell lung cancer

Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer

Preclinical rationale for combining radiation therapy and immunotherapy beyond checkpoint inhibitors (i.e., CART)

Clinical decision tool for optimal delivery of liver stereotactic body radiation therapy: Photons versus protons

NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model

Suchergebnisse filtern